SAGENT PHARMS INC FDA Approval ANDA 204751

ANDA 204751

SAGENT PHARMS INC

FDA Drug Application

Application #204751

Documents

Letter2017-08-29

Application Sponsors

ANDA 204751SAGENT PHARMS INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION0.004MG/ML0DESMOPRESSIN ACETATEDESMOPRESSIN ACETATE

FDA Submissions

UNKNOWN; ORIG1AP2017-08-22STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

SAGENT PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204751
            [companyName] => SAGENT PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"DESMOPRESSIN ACETATE","activeIngredients":"DESMOPRESSIN ACETATE","strength":"0.004MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/22\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/204751Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"07\/25\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-07-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.